| Closed |
S1320 |
Melanoma - Ph II Intermittent vs Continuous Dabrafenib and Trametinib BRAF Positive Melanoma |
7/22/2014 |
7/15/2019 |
100% |
|
|
| Closed |
S9716 |
Merkel Cell Carcinoma |
10/15/1998 |
8/15/2000 |
7% |
|
|
| Closed |
S9810 |
Mesothelioma |
2/15/1999 |
8/15/2000 |
100% |
|
Published
|
| Closed |
S1014 |
Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II |
8/9/2011 |
8/1/2013 |
98% |
|
Published
|
| Closed |
S1216 |
Metastatic Prostate Cancer, Phase III ADT+TAK-700 vs. ADT+Bicalutamide |
3/1/2013 |
7/15/2017 |
100% |
|
|
| Closed |
SWOG-9005 |
Mifepristone in Unresectable Meningioma |
8/15/1992 |
7/1/1998 |
86% |
|
Published
|
| Closed |
S1823 |
miRNA 371 Study in Germ Cell Tumors |
6/1/2020 |
|
100% |
|
|
| Closed |
SWOG-9333 |
Mito/VP-16 vs DNR/Ara-C for Elderly AML |
1/15/1995 |
12/1/1998 |
84% |
|
Published
|
| Closed |
SWOG-8608 |
Mitoxantrone Plus Cis-Platinum in Patients with Advanced Breast Cancer |
2/16/1987 |
8/1/1989 |
|
|
Published
|
| Closed |
S1404 |
MK-3475, Interferon, Resected High-Risk Melanoma |
10/15/2015 |
|
98% |
|
|
| Closed |
S0424 |
Molecular Epidemiology |
10/1/2005 |
3/15/2011 |
100% |
|
|
| Closed |
SWOG-7406 |
MOPP #5 in Advanced Hodgkin's Disease |
8/23/1974 |
6/7/1978 |
|
|
Published
|
| Open |
S1827 |
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) |
1/10/2020 |
|
37% |
|
|
| Closed |
SWOG-7924 |
Multimodal Therapy for Limited Small Cell Carcinoma of the Lung |
11/2/1979 |
10/29/1982 |
|
|
Published
|
| Closed |
SWOG-8313 (EST 5186) |
Multiple Drug Adjuvant Chemotherapy for Patients with ER Negative Stage II Carcinoma of Breast |
4/20/1984 |
6/15/1990 |
100% |
|
Published
|
| Closed |
S1011 |
Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III |
8/1/2011 |
4/15/2017 |
100% |
|
|
| Closed |
S0309 |
Myeloma Repository |
11/15/2003 |
|
|
|
|
| Open |
MYELOMATCH |
myeloMATCH MSRP |
5/16/2024 |
|
|
|
|
| Closed |
S1934 |
NASSIST |
9/9/2021 |
3/1/2023 |
0% |
|
|
| Closed |
SWOG-8923 |
Neo-FAC for Poor Prognosis St.IV Breast Cancer |
2/15/1990 |
6/1/1992 |
60% |
|
Published
|
